Direct-to-consumer wellness startup Aarus has officially launched in India, positioning its offerings around functional ingredients delivered through everyday formats such as cocoa drinks, sweeteners, and chewing gum. Notably, the company aims to provide an alternative to conventional pill-based supplements while improving long-term consumer adoption.
Moreover, incubated by the Kanoria Foundation, Aarus is targeting what it describes as the “adherence gap” in preventive healthcare. While many consumers purchase supplements, they often fail to maintain consistent usage. Therefore, Aarus embeds clinically formulated compounds into familiar daily formats, eliminating the need for users to build entirely new habits.
In line with this strategy, the company has introduced its first product, Drift, a nighttime cocoa blend designed to support sleep. The formulation combines botanical extracts, amino acids, and essential minerals, thereby aligning with existing post-dinner routines. As a result, Drift reframes supplementation as a habit-linked ritual rather than a clinical intervention. Additionally, the company revealed that early closed-cohort testing demonstrated improvements in sleep onset and overall sleep quality, with some users even replacing late-night snacking with the drink.
Initially, Drift will launch through a waitlist model before expanding into broader online distribution channels. This phased rollout allows the company to refine its product based on real user feedback.
“We are building products that people can adopt effortlessly by embedding them into their existing routines, rather than asking them to create new ones,” said Yagyesh Kanoria, Founder of Aarus.
“At a broader level, the challenge in preventive healthcare is not just access but consistency—people start with intent but often don’t sustain usage. Our focus is on improving adherence by designing formats that fit naturally into daily life. This approach aligns with a broader global shift, where markets such as the US and Europe are moving away from traditional pill-based supplementation toward products embedded within everyday consumption. We combine scientific rigour with familiar formats, while continuously learning from user behaviour to refine both formulation and delivery.”
Looking ahead, Aarus is building a diversified product pipeline. It includes a focus-enhancing low-calorie sweetener, a mineral-rich salt alternative aimed at reducing sodium intake, and a collagen-support chewing gum. Furthermore, Kanoria, who brings expertise in biochemistry and pharmaceuticals, emphasised that launch timelines will depend on ongoing consumer feedback. Over time, the company plans to expand across multiple wellness categories while strengthening its product-market fit.
Aarus is aligning itself with a growing global shift toward functional, habit-integrated wellness solutions. By combining scientific formulation with everyday consumption formats, the startup is well-positioned to address the critical challenge of consistency in preventive healthcare while tapping into the rapidly evolving D2C wellness market.
